Добавил:
kiopkiopkiop18@yandex.ru Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

6 курс / Клинические и лабораторные анализы / Лабораторная_диагностика_туберкулеза_Ерохин_В_В_ред_

.pdf
Скачиваний:
20
Добавлен:
24.03.2024
Размер:
6.25 Mб
Скачать

 

berculosis H37Rv and the attenuated M.tuberculosis H37Ra strain // In-

 

 

fect. Immun. – 1999. – Vol. 67. – P. 5768–5774.

 

74. Brosch R., Pym A.S., Gordon S.V., Cole S.T. The evolution of mycobac-

 

terial pathogenicity: clues from comparative genomics // Trends Micro-

 

biol. – 2001. – Vol. 9 – P. 452–458.

 

75. Brudey K., Driscoll J., Rigouts L. et al. Mycobacterium tuberculosis com-

 

plex genetic diversity: mining the fourth international spoligotyping data-

 

base (SpolDB4) for classification, population genetics and epidemiology

 

// BMC Microbiol. 2006; 6: 23.

 

76. Bustin S.A. Real-Time PCR. Encyclopedia of Diagnostic Genomics and

 

Proteomics. – 2005. – P. 1117–1125.

 

77.Bustin S.A. Absolute quantification of mRNA using real-time reverse tran-

 

scription polymerase chain reaction assays // J Mol Endocrinol. – 2000.

 

– Vol. 25(2). – P. 169–193.

 

78. Bustin S.A. Developments in real-time PCR research and molecular di-

 

agnostics // Expert Rev Mol Diagn. – 2010. – Vol. 10(6). – P. 713–715.

 

79.Cave M. D., Eisenach K.D., Templeton G., Salfinger M., Mazurek G.,

 

Bates J.H., Crawford J.T. Stability of DNA fingerprint pattern produced

 

with IS6110 in strains of Mycobacterium tuberculosis // J. Clin. Microbiol.

 

– 1994. – Vol. 32. – P. 262–266.

 

80. Cave M.D., Murray M., Nardell E. Molecular epidemiology of Mycobac-

 

terium tuberculosis // Tuberculosis and the tubercle bacillus / Edited by

 

S.T. Cole. – Washington, ASM Press. – 2005. – P. 33–46.

 

81. Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., Gor-

 

don S.V., Eiglmeier K., Gas S., Barry 3rd C.E., Tekaia F., Badcock K.,

 

Basham D., Brown D., Chillingworth T., Connor R., Davies R., Devlin

 

K., Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,

 

Krogh A., McLean J., Moule S., Murphy L., Oliver K. Osborne J., Quail

 

M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton J.,

 

Squares R., Squares S., Sulston J.E., Taylor K., Whitehead S., Barrell

РЕКОМЕНДАЦИИ

B.G. Deciphering the biology of Mycobacterium tuberculosis from the

complete genome sequence // Nature. – 1998. – Vol. 393. – P. 537–544.

 

 

82. Collins C.H., Grange J.M., Yates M.D. Tuberculosis Bacteriology. 2nd

 

ed. Organization and Practicе. Oxford: Butterworth-Heinemann,1997.

 

83.Collins D.M., Stephens D.M. Identification of an insertion sequence,

 

IS1081, in Mycobacterium bovis // FEMS Microbiol Lett. – 1991. – Vol.

МЕТОДИЧЕСКИЕ

67(1). – P. 11–15.

84. Cows M., Drobniewski F. Molecular techniques in the diagnosis of My-

 

 

cobacterium tuberculosis and the detection of drug resistance. – 2003.

 

 

 

518

85. Daley C.L., Griffith D.E. Pulmonary non-tuberculous mycobacterial in-

 

 

fections // Int. J. Tuberc. Lung Dis. – 2010. – Vol. 14, № 6. – Р. 665–

 

671.

 

86. David L., Heyman М. Diseases due to other mycobacteria. – Washing-

 

ton: American Public Health Association. – 2004. – Р. 572–573.

 

87. Deb C., Lee C.M., Dubey V.S., Daniel J., Abomoelak B. et al. A novel

 

in vitro multiple-stress dormancy model for Mycobacterium tuberculosis

 

generates a lipid-loaded, drug-tolerant, dormant pathogen //PLoS One.

 

– 2009. – 4:e6077.

 

88. Eltringham I. J., Drobniewski F. Multiple drug resistant tuberculosis: ae-

 

tiology, diagnosis and outcome // Br. Med. Bull. – 1998. – № 54. – Р.

 

569–578.

 

89. Emerging Infections 5. Ed. by W.M. Scheld, W.A. Craig, J.M. Hughes/

 

ASM Press, Washington, 2001.–chp9, – P. 137–152.

 

90. Enarson D.A., Rieder H.L., Arnadottir T. – Technical Guide for Sputum

 

Examination for Tuberculosis by Direct Microscopy. IUATLD. – 1994.

 

– P. 49–64.

 

91.Espy M. J., Uhl J. R., Sloan L. M., Buckwalter S. P., Jones M. F., Vetter

 

E. A., Yao J. D. C., Wengenack N. L., Rosenblatt J. E., Cockerill F. R.

 

III, Smith T. F. Real-Time PCR in Clinical Microbiology: Applications for

 

Routine Laboratory Testing // Clin. Microbiol. Rev. – 2006. – Vol. 19. –

ЭКЗАМЕНА

Chest Med. – 2002. – Vol. 23. – P. 529–551.

P. 165–256.

 

92. Falkinham J.O. Nontuberculous Mycobacteria in the environment. // Clin

ПРОВЕДЕНИЮ

93. Falkinham J.O., III Epidemiology of Infection by Nontuberculous My-

 

cobacteria // Clinical Microbiology Reviews. 1996. – Vol. 9 (2). – P.

 

177–215.

 

94. Feinberg M., Fernandez S., Cassard S., Bertheau Y. Quantitation of 35S

 

promoter in maize DNA extracts from genetically modified organisms

К

using real-time polymerase chain reaction, part 2: interlaboratory study.

МАТЕРИАЛЫ

JAOAC Int. – 2005. – Vol. 88(2). – P. 558–573.

 

95. Fleischmann R.D., Alland D., Eisen J.A., Carpenter L., White O., Pe-

 

terson J., DeBoy R., Dodson R., Gwinn M., Haft D., Hickey E.,

 

Kolonay J.F., Nelson W.C., Umayam L.A., Ermolaeva M., Salzberg S.

МЕТОДИЧЕСКИЕ

L., Delcher A., Utterback T., Weidman J., Khouri H., Gill J., Mikula A.,

 

Bishai W., Jacobs W. R. Jr, Venter J.C., Fraser C.M. Whole–genome

 

comparison of Mycobacterium tuberculosis clinical and laboratory strains

 

// J. Bacteriol. – 2002. – Vol. 184. – P. 5479–5490.

 

96. Gale, E. F., E. Cundliffe, P. E. Reynolds, M. H. Richmond, and M. J.

4.

Waring. 1981. The molecular basis of antibiotic action. John Wiley &

Раздел

Sons, Inc., New York.

 

 

 

 

519

 

97.Garvin R. T., Biswas D. K., Gorini L. The effects of streptomycin or dihy-

 

 

drostreptomycin binding to 16S rRNA or to 30S ribosomal subunits //

 

Proc. Natl. Acad. Sci. USA. – 1974. – Vol. 71. – P. 3814–3818.

 

 

98. Gengenbacher M., Kaufmann S.H. Mycobacterium tuberculosis: success

 

through dormancy // FEMS Microbiol. Rev. – 2012. – Vol. 36(3). – P.

 

514–532.

 

 

 

 

 

 

 

99.Global

tuberculosis

control:

WHO

report

2011

 

(WHO/HTM/TB/2011.16).

 

 

 

 

 

 

100. Gori A., Bandera A., Marchetti G., Esposti A. D., Catozzi L., Nardi

 

G. P., Gazzola L., Ferrario G., van Embden J. D., van Soolingen D.,

 

Moroni M., Franzetti F. Spoligotyping and Mycobacterium tuberculosis//

 

Emerg. Infect. Dis. – 2005. – Vol. 11(8). – P. 1242.

 

 

 

 

101. Griffith D.E., Aksamit T., Brown-Elliott B.A. et al. An official

 

ATS/IDSA statement: diagnosis, treatment, and prevention of Nontu-

 

berculous Mycobacterial diseases. // Am J Respir Crit Care Med. 2007.

 

– Vol. 175. – P. 367–416.

 

 

 

 

 

 

102. Guillemin V., Jarlier V., Cambau E. Correlation between quinolone sus-

 

ceptibility patterns and sequences in the A and B subunits of DNA gyrase

 

in mycobacteria// Antimicrob. Agents Chemother. – 1998. – Vol. 42. –

 

P. 2084–2088.

 

 

 

 

 

 

103. Gutacker M. M., Mathema B., Soini H., Shashkina E., Kreiswirth B.

 

N., Graviss E. A., Musser J. M. Single–Nucleotide Polymorphism–

 

Based Population Genetic Analysis of Mycobacterium tuberculosis Strains

 

from 4 Geographic Sites // J. Infect. Dis. – 2006. – Vol. 193. – P. 121–

 

128.

 

 

 

 

 

 

 

104. Gutacker M. M., Smoot J. C., Lux Migliaccio C. A., Ricklefs S. M.,

 

Hua S., Cousins D. V., Graviss E. A., Shashkina E., Kreiswirth B.,

 

Musser J. M. Genome-wide analysis of synonymous single nucleotide

 

polymorphisms in Mycobacterium tuberculosis complex organisms: Res-

 

olution of genetic relationships among closely related microbial strains.

РЕКОМЕНДАЦИИ

// Genetics. – 2002. – V. 162. – P. 1533–1543.

 

 

 

105. Gutierrez M. C., Brisse S., Brosch R., Fabre M., Omais B., Marmiesse

 

 

M., Supply P., Vincent V. Ancient origin and gene mosaicism of the pro-

 

genitor of Mycobacterium tuberculosis // PLoS Pathog. – 2005. – Vol. 1

 

(1). – e5.

 

 

 

 

 

 

 

106. Hahn H., Kaufmann S.H.E., Schulz T.F., Suerbaum S. Medizinische

МЕТОДИЧЕСКИЕ

Microbiologie und Infectologie // Springer Heidelberg – 2009. – T.42.

– S. 354–369.

 

 

 

 

 

 

 

 

 

 

 

 

107. Hillemann D., Rusch-Gerdes S., Richter E. Evaluation of the Geno-

 

Type MTBDRplus Assay for Rifampin and Isoniazid Susceptibility Test-

 

 

 

 

 

 

 

 

520

ing of Mycobacterium tuberculosis Strains and Clinical Specimens// J Clin

 

 

Microbiol. – 2007. – № 45(8). – Р. 2635–2640.

 

108. Kamerbeek J., Schouls L., Kolk A., van Agtervveld M., van Soolingen

 

D., Kuijper S., Bunschoten A., Molhuizen H., Shaw R., Goyal M., van

 

Embden J.D.A. Simultaneous detection and strain differentiation of My-

 

cobacterium tuberculosis for diagnosis and epidemiology // J. Clin. Micro-

 

biol. – 1997. – Vol. 35. – P. 907–914.

 

109. Kantor I.N., Kim S.J., Frieden T. et al. Laboratory Services in Tuber-

 

culosis Control. Parts I–II. – 1998. – Switzerland, Geneva, WHO.

 

110. Kapur V., Whittam T.S., Musser J.M. Is Mycobacterium tuberculosis

 

15,000 years old? // J. Infect. Dis. – 1994. – Vol. 170. – P. 1348–1349.

 

111. Kent P.T., Kubica G.P. Public Health Mycobacteriology. A Guide for

 

the Level III Laboratory. Centers for Disease Control, 1985. – 207 pp.

 

112. Koch R. Die Aetiologie der Tuberkulose, 19:221-230; 1882 Wayne L.G.,

 

Kubica G.P. Family Mycobacteriacease In: Holt J.G., Sneath P.H.A.,

 

eds. Bergey's manual of detrminative bacteriology, 9th ed. Baltimor:

 

Williams and Wilkins, 1985.

 

113. Kox L.F., van Leeuwen J., Knijper S., Jansen H.M., Kolk A.H. PCR

 

assay based on DNA coding for 16S rRNA for detection and identification

 

of mycobacteria in clinical samples // J. Clin. Microbiol. – 1995. – Vol.

 

33 (12) – P. 3225–3233.

ЭКЗАМЕНА

Yakrus M. A., Musser J. M., van Embden J. D. Comparison of methods

114. Kremer K., van Soolingen D., Frothingham R., Haas W. H., Hermans

 

P. W., Martin C., Palittapongarnpim P., Plikaytis B. B., Riley L. W.,

ПРОВЕДЕНИЮ

based on different molecular epidemiological markers for typing of My-

 

cobacterium tuberculosis complex strains: interlaboratory study of discrim-

 

inatory power and reproducibility // J. Clin. Microbiol. – 1999. – Vol. 37.

 

– P. 2607–2618.

 

115. Kruuner A., Yates M., Drobniewski F. Critical concentration setting

К

and evaluation of MGIT 960 antimicrobial susceptibility testing to first-

МАТЕРИАЛЫ

and second line antimicrobial drugs with clinical drug resistant strains of

 

Mycobacterium tuberculosis // J. Clin. Microbiol. – 2006. – № 44. – Р.

 

811–818.

 

116. Lee A.S., Jelfs P., Sintchenko V., Gilbert G.L. Identification of non-tu-

МЕТОДИЧЕСКИЕ

berculous mycobacteria: utility of the GenoType Mycobacterium CM/AS

 

assay compared with HPLC and 16S rRNA gene sequencing. //J. Med.

 

Microbiol. – 2009. – Vol. 58. – P. 900–904.

 

117. Lung biology in Health and Disease. v.219. Reichman ahd Hershfield’

 

Tuberculosis. A comprehensive, International Approach. Third Edition.

4.

Informa Healthcare USA. – 2006.–715.

Раздел

 

 

 

 

 

521

 

118. Mahillon J., Chandler M. Insertion Sequences // Microbiology and Mo-

 

 

lecular Biology Reviews. – 1998. – P. 725–774.

 

119. Maus C. E., Plikaytis B. B., Shinnick T. Molecular Analysis of Cross-

 

Resistance to Capreomycin, Kanamycin, Amikacin, and Viomycin in

 

Mycobacterium tuberculosis// Antimicrob. Agents Chemother. – 2005. –

 

Vol. 49. – P. 3192–3197.

 

120. Maus C.E., Plikaytis B.B., Shinnick T.M. Mutation of tlyA confers

 

capreomycin resistance in Mycobacterium tuberculosis// Antimicrob.

 

Agents Chemother. – 2005. – Vol. 49. – P. 571–577.

 

121. Miesel L., Rozwarski D.A., Sacchettini J.C., Jacobs Jr. W. R. Mecha-

 

nisms for isoniazid action and resistance// Novartis Found Symp. –

 

1998. – Vol. 217. – P. 209–221.

 

122. Migliori G. B., Lange C., Girardi E. et al. Extensively drug-resistant

 

tuberculosis is worse than multidrug-resistant tuberculosis: different

 

methodology and settings, same results // Clin Infect Dis. – 2008. – №

 

46. – Р. 958–959.

 

123. Mikhailovich V., Lapa S., Gryadunov D., Sobolev A., Strizhkov B.,

 

Chernyh N., Skotnikova O., Irtuganova O., Moroz A., Litvinov V.,

 

Vladimirskii M., Perelman M., Chernousova L., Erokhin V., Zasedatelev

 

A., Mirzabekov A. Identification of rfampin-resistant Mycobacterium tu-

 

berculosis strains by hybridization, PCR, and ligase detection reaction on

 

oligonucleotide microchips // J. Clin. Microbiol. – 2001. – Vol. 39. – P.

 

2531–2540.

 

124. Mitchinson D.A., Nunn A.J. Influence of initial drug resistance on the

 

response to short-course chemotherapy of pulmonary tuberculosis// Am

 

Rev Respir Dis. – 1986. – № 133. – Р. 423–430.

 

125. Mokrousov I, Narvskaya O, Vyazovaya A, Millet J, Otten T, Vishnevsky

 

B, Rastogi N. Mycobacterium tuberculosis Beijing genotype in Russia: in

 

search of informative variable-number tandem-repeat loci // J Clin Mi-

 

crobiol. – 2008. – Vol. 46(11). – P. 3576–3584.

РЕКОМЕНДАЦИИ

126. Mokrousov I, Otten T, Zozio T, Turkin E, Nazemtseva V, Sheremet A,

Vishnevsky B, Narvskaya O, Rastogi N. At Baltic crossroads: a molecular

 

 

snapshot of Mycobacterium tuberculosis population diversity in Kalin-

 

ingrad, Russia // FEMS Immunol Med Microbiol. – 2009. – Vol. 55(1).

 

– P. 13–22.

 

127. Mokrousov I., Narvskaya O., Limeschenko E., Otten T., Vyshnevskiy B.

МЕТОДИЧЕСКИЕ

Detection of ethambutol-resistant Mycobacterium tuberculosis strains by

multiplex Allele-Specific PCR assay targeting embB306 mutations// J.

 

 

Clin. Microb. – 2002. – Vol. 40. – P. 1617–1720.

 

 

 

522

128. Murphy D.J., Brown J.R. Identification of gene targets against dormant

 

 

phase Mycobacterium tuberculosis infections // BMC Infect.Dis. – 2007.

 

– Vol. 7. – P. 84.

 

129. Mykobacterien und mykobacterielle Krankheiten/G.Meissner. – Veb

 

G.Fischer Verlag Jena. – 1980. – 377s.

 

130. Neelsen P. Zentralblatt fur de Medizinischen Wissenschafen – 1883. –

 

V.21, P. 497.

 

131. Ngamlert K., Sinthuwattanawibool C., McCarthy K.D., Sohn H.,

 

Starks A., Kanjanamongkolsiri P., Anek-vorapong R., Tasaneeyapan T.,

 

Monkongdee P., Diem L., Varma J.K. Diagnostic performance and costs

 

of Capilia TB for Mycobacterium tuberculosis complex identification from

 

broth-based culture in Bangkok, Thailand // Trop Med Int Health. –

 

2009. – Vol. 14(7). – P. 748–753.

 

132. Park H., Jang H., Kim Ch., Chung B., Chang Ch.L., Park S.K., Song

 

S. Detection and identification of Mycobacteria by amplification of the in-

 

ternal transcribed spacer regions with genusand species-specific PCR

 

primers // J. Clin. Microbiol. – 2000. – Vol. 38. – P. 4080–4085.

 

133. Petersen K F. Methods for internal quality control in the mycobacteri-

 

ology laboratory. Zentralbl Bakteriol Mikrobiol Hyg 1983; 255: 503–510.

 

Laboratory services in tuberculosis control. Part I: Organization and

 

management. – 1998. – 64 pp.

ЭКЗАМЕНА

BACTEC MGIT 960 system // J. Clin Microbiol. – 2002. – № 40. – Р.

134. Pfyffer G. E., Palicova F., and Rusch-Gerdes S. Testing of susceptibility

 

of Mycobacterium tuberculosis to pyrazinamide with the nonradiometric

ПРОВЕДЕНИЮ

1670–1674.

 

135. Popov S., Puzanov V., Sabgaida T., Antonova N. The reality of TB lab

 

risks during the national TB program performance. Russian Federation.

 

// Eur.Resp.J. – 2004. – Vol. 24. – Suppl. 48. – P1249. – 198s.

 

136. Prabhakar S., Mishra A., Singhal A., Katoch V.M., Thakral S.S., Tyagi

К

J.S., Prasad H.K. Use of the hupB gene encoding a histone-like protein of

МАТЕРИАЛЫ

Mycobacterium tuberculosis as a target for detection and differentiation of

 

M.tuberculosis and M.bovis // J. Clin. Microbiol. – 2004. – Vol. 42. – P.

 

2724–2732.

 

137. Puzanov V., V. Golyshevskaya, S. Popov, I. Danilova, H. Kluge, W.

МЕТОДИЧЕСКИЕ

Jakubowiak External quality assessment programs of bacteriological di-

 

agnosis of TB in Russia: challenges and adjustments, introduction and

 

development// Пульмонология, 2004. Supplement, Abstract book, 3-

 

rd Congress of European region IUATLD, 267, p.73.

 

138. Puzanov V.A., Punga V.V., Katulina N.I., Danilova I.D., Kluge H. De-

4.

tection of pulmonary TB patients by Ziehl-Neelsen microscopy at clin-

Раздел

 

 

 

 

 

523

 

ical diagnostic laboratories in the pilot regions of Russia. // Pneumologia.

 

 

– Vol. LI, nr. 2, 2002,– P 140, p.126–127.

 

139. Quemard A., Sacchettini J. C., Dessen A., Vilcheze C., Bittman R., Ja-

 

cobs Jr. W. R., Blanchard J. S. Enzymatic characterization of the target

 

for isoniazid in Mycobacterium tuberculosis// Biochemistry. – 1995. –

 

Vol. 34. – P. 8235–8241.

 

140. Rattan A., Kalia A., Ahmad N. Multing-Resistant Mycobacterium tu-

 

berculosis: Molecular Perspectives. 1998.

 

141. Richter E., Rьsch-Gerdes S., Hillemann D. Evaluation of the Geno-

 

Type Mycobacterium Assay for Identification of Mycobacterial Species

 

from Cultures // J. Clin. Microbiol. – 2006. – Vol. 44. – P. 1769–1775.

 

142. Rieder H L, Van Deun A, Kam K M, et al. Priorities for tuberculosis

 

bacteriology services in low income countries. 2nd ed. Paris, France: In-

 

ternational Union Against Tuberculosis and Lung Disease, 2007.

 

143. Rossman M.D., MacGregor R.R. Tuberculosis: clinical management

 

and new challenges // McGraw Hill Inc., New York, 1995.

 

144. Runion E.H. Anonymous mycobacteria in pulmonary disease. Med.

 

Clin. North Am., 1959, 43, 273–290.

 

145. Runion E.H. Mycobacteria encounted in clincal lаboratories. Leprosy

 

Briefs, 1958, 9, 21–23.

 

146. Runion E.H. Pathogenic mycobacteria. Adv. Tuberc. Res., 1965, 14,

 

235–287

 

147. Runion E.H., Karlson A.G., Kubica G.P., Wayne L.G. Mycobacterium.

 

In: Lennette E.H., Spaudling E.H., Truant J.P., eds. Manual of clinical

 

microbiology. 2-d ed. Washington DC: American Society of Microbiol-

 

ogy. 1974, 148–174.

 

148. Rusch-Gerdes S., Domehl C., Nardi G. et al. Multicenter evaluation

 

of the mycobacteria growth indicator tube for testing susceptibility of My-

 

cobacterium tuberculosis to first-line drugs // J Clin Microbiol. – 1999.

 

– № 37. – Р. 45–48.

РЕКОМЕНДАЦИИ

149. Rusch-Gerdes S., Pfyffer G. E., Casal M. et al. Multicenter laboratory

validation of the BACTEC MGIT 960 technique for testing susceptibilities

 

 

of Mycobacterium tuberculosis to classical second-line drugs and newer an-

 

timicrobials // J. Clin. Microbiol. – 2006. – № 44. – Р. 6886–6892.

 

150. Russo C., Tortoli E., MenichellaD. Evaluation of the New GenoType My-

 

cobacterium Assay for Identification of Mycobacterial Species // J. Clin.

МЕТОДИЧЕСКИЕ

Microbiol. – 2006. – Vol. 44. – P. 334–339.

151. S A Bustin, V Benes, T Nolan, M W Pfaffl. Quantitative real-time RT-

 

 

PCR – a perspective. J. Mol. Endocrinol., Ju№ 2005; 34: 597–601.

 

152. Said H.M., Ismail N., Osman A., Velsman C., Hoosen A.A. Evaluation

 

of TBc identification immunochromatographic assay for rapid identification

 

 

 

524

of Mycobacterium tuberculosis complex in samples from broth cultures //

 

 

J. Clin. Microbiol. – 2011. – Vol. 49 (5). – P. 1939–1942.

 

153. Samoskovi A., Parsons L., Salfinger M. The molecular basis of resist-

 

ance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuber-

 

culosis. 2001.

 

154. Sato A. Geographic distribution of MAIC serovars isolated from pa-

 

tients in five cities of Japan // Kansenshogaku Zasshi. – 2000. – Vol. 74.

 

– № 1. – P. 64–72.

 

155. Schmittgen T.D. Real-time quantitative PCR. Methods. – 2001. – Vol.

 

25(4). – P. 383–385.

 

156. Scorpio A., Zhang Y. Mutations in pncA, a gene encoding pyrazinami-

 

dase/nicotinamidase, cause resistance to the antituberculous drug pyraz-

 

inamide in tubercle bacillus // Nat. Med. – 1996. – Vol. 2. – P. 662–667.

 

157. Shekarabi M., Oormazdi M., Ghamchili A., Razavi S.M. A comparative

 

study on the two methods of direct fluorescent antibody and Kynion acid-

 

fast staining techniques on the laboratory diagnosis of cryptosporidiosis

 

// J. of Iran Un. of Med. Sc. – 2001. – V.8(25). – P. 300–307.

 

158. Shinnick T M, Iademarco M F, Ridderhof J C. National plan for reli-

 

able tuberculosis laboratory services using a systems approach. Recom-

 

mendations from CDC and the Association of Public Health Laborato-

 

ries Task Force on Tuberculosis Laboratory Services // MMWR Recomm

ЭКЗАМЕНА

Rep. – 2005. – Vol. 54. – P. 1–12.

159. Shitikov E., Ilina E., Chernousova L., Borovskaya A., Rukin I.,

Afanas’ev M., Smirnova T., Vorobyeva A., Larionova E., Andreevskaya

S., Kostrzewa M., Govorun V. Mass spectrometry based methods for the

ПРОВЕДЕНИЮ

 

discrimination and typing of mycobacteria // J. Infection, Genetics and

 

Evolution. – 2012. – Vol. 12. – P. 838–845.

 

160. Siddiqi S H. MGIT procedure manual for BACTEC MGIT 960 TB sys-

 

tem. Sparks, MD, USA: Becton Dickinson. – 2005. – p 81–84.

К

161. Siddiqi S., Rusch-Gerdes S. Руководство по работе с системой

МАТЕРИАЛЫ

BACTEC MGIT 960 // FIND diagnostics. – 2006. – 74с.

 

162. Siddiqi S., Rusch-Gerdes S., Alexander H. et al. MGIT Procedure

 

Manual. For BACTEC MGIT 960 TB System (Also applicable for Man-

 

ual MGIT) Mycobacteria Growth Indicator Tube (MGIT) Culture and

МЕТОДИЧЕСКИЕ

Drug Susceptibility Demonstration Projects – 2007.

 

163. Smith I. Mycobacterium tuberculosis pathogenesis and molecular deter-

 

minants of virulence // Clin. Microb. Rev. – 2003. – Vol. 16 (3). – P.

 

463–496.

 

164. Smithwick R.W. – Laboratory Manual for Acid-fast Microscopy. 2nd

4.

ed. Atlanta: Centers for Disease Control, 1976.

Раздел

 

 

 

 

 

525

 

165. Sonnhammer E.L., Durbin R. A workbench for large-scale sequence ho-

 

 

mology analysis // Comput Appl Biosci. – 1994. – Vol. 10. – P. 301–307.

 

166. Sreevatsan S., Pan X., Stockbauer K.E., Connell N.D., Kreiswirth B.N.,

 

Whittam T.S., Musser J.M. Restricted structural gene polymorphism in

 

the Mycobacterium tuberculosis complex indicates evolutionarily recent

 

global dissemination // Proc. Natl. Acad. Sci. USA. – 1997. – Vol. 94. –

 

P. 9869–9874.

 

167. Sreevatsan S., Stochbauer K.E., Pan. X, Kreiswirth B. N., Moghazeh

 

S., Jacobs W., Telenti A., J. Musser. Ethambutol resistance in Mycobac-

 

terium tuberculosis: critical role of embB mutations// Antimicrob. Agents

 

Chemother. – 1997. – Vol. 41. – P. 1677–1681.

 

168. Supply P., Allix C., Lesjean S., Cardoso-Oelemann M., Rusch-Gerdes,

 

S., Willery E., Savine E., de Haas P., van Deutekom H., Roring S., Bifani

 

P., Kurepina N., Kreiswirth B., Sola C., Rastogi N., Vatin V., Gutierrez

 

M. C., Fauville M., Niemann S., Skuce R., Kremer K., Locht C., D. van

 

Soolingen. Proposal for Standardization of Optimized Mycobacterial In-

 

terspersed Repetitive Unit-Variable-Number Tandem Repeat Typing of

 

Mycobacterium tuberculosis// J. Clin. Microbiol. – 2006. – Vol. 44. – P.

 

4498–4510.

 

179. Supply P., Mazars E., Lesjean S., Vincent V., Gicquel B., Locht C. Vari-

 

able human minisatellite–like regions in the Mycobacterium tuberculosis

 

genome // Mol. Microbiol. – 2000. – Vol. 36. – P. 762–771.

 

170. Susceptibility testing of Mycobacteria, Nocardiae and other aerobic

 

Actinomycetes; Approved Standards. – M 24–A. – Vol. 23. – №18.

 

171. Telenti A., Imboden P., Marchesi F., Matter L., Schopfer K., Bodmer

 

T., Lowrie D., Colston M. J., ColeS. Detection of rifampicin-resistance

 

mutations in Mycobacterium tuberculosis// Lancet. – 1993. – Vol. 341

 

(8846). – P. 647–651.

 

172. Tenover F.C., Crawford J.T., Huebner R.E., Geiter L.J., Horsburgh

 

C.R. Jr, Good R.C. The resurgence of tuberculosis: is your laboratory

РЕКОМЕНДАЦИИ

ready? // J Clin Microbiol. – 1993. – Vol. 31. – P. 767–770.

173. Thibault V.C., Grayon M., Boschiroli M. L., Hubbans., Overduin P.,

 

 

Stevenson K., Gutierrez M.C., Supply Ph., Biet F. New Variable-Number

 

Tandem-Repeat markers for typing Mycobacterium avium subsp. paratu-

 

berculosis and M. avium strains: comparison with IS900 and IS1245 Re-

 

striction Fragment Length Polymorphism typing. Published ahead of print

МЕТОДИЧЕСКИЕ

30 May 2007, doi: 10.1128/JCM.00476-07

174. Timple A, Runion E.H. The relationship of atypical acid-fast bacteria

 

 

to human disease //J. Laor. Clin. Med. – 1954. – Vol. 44. – P. 202–209.

 

 

 

526

175. Traccas J.A., Gicquel B. Life on the inside: Probing Mycobacterium tu-

 

 

berculosis gene expression during infection // Immun.Cell Biol. – 2000.

 

– Vol. 78. – P. 311–317.

 

176. van Embden J.D., Cave M.D., Crawford J.T., Dale J.W., Eisenach K.D.,

 

Gicquel B., Hermans P., Martin C., McAdam R., Shinnick T.M. Strain

 

identification of Mycobacterium tuberculosis by DNA fingerprinting: rec-

 

ommendations for a standardized methodology // J. Clin. Microbiol. –

 

1993. – Vol. 31(2). – P. 406–409.

 

177. van Embden J.D.A, van Gorkom T., Kremer K., Jansen R., van Der Zeijst

 

B.A., Schouls L.M. Genetic variation and evolutionary origin of the direct

 

repeat locus of Mycobacterium tuberculosis complex bacteria // J. Bacte-

 

riol. – 2000. – Vol. 182. – P. 2393–2401.

 

178. Van Soolingen D., de Haas P. E., van Doorn H. R., Kuijper E., Rinder

 

H., Borgdorff M.W. Mutations at amino acid positio№ 315 of the katG

 

gene are associated with high-level resistance to isoniazid, other drug re-

 

sistance, and successful transmission of Mycobacterium tuberculosis in the

 

Netherlands // J. Infect. Dis. – 2000. – Vol. 182. – P. 1788–1790.

 

179. van Soolingen D., Hermans P.W., de Haas P.E., Soll D.R., van Embden

 

J.D. Occurrence and stability of insertion sequences in Mycobacterium

 

tuberculosis complex strains: evaluation of an insertion sequence–depen-

 

dent DNA polymorphism as a tool in the epidemiology of tuberculosis //

ЭКЗАМЕНА

sertion element IS1081-associated restriction fragment length polymor-

J. Clin. Microbiol. – 1991. – Vol. 29. – P. 2578–2586.

 

180. van Soolingen D., Hermans P.W., de Haas P.E., van Embden J.D. In-

ПРОВЕДЕНИЮ

phisms in Mycobacterium tuberculosis complex species: a reliable tool for

 

recognizing Mycobacterium bovis BCG // J. Clin. Microbiol. – 1992. –

 

Vol. 30(7). – P. 1772–1777.

 

181. Vasylieva I.,Samoilova A., Larionova E., Chernousova L. Impact of

 

rapid diagnostics of M.tuberculosis drug resistance by GenoType MTB-

К

DRplus GenoType MTBDRsl (Hain Lifescience GmbH, Germany) on

МАТЕРИАЛЫ

efficacy of treatment of MDR/XDR TB patients // Am. J. Respir. Crit.

 

Care Med. – 2012. – Vol. 185. – A3313.

 

182. Von Rhein C.F., Arbeit R.D., Horsburgh R., Ristola M.A., Waddell

 

R.D., Tvaroha S.M. et al. Sources of disseminated Mycobacterium avium

МЕТОДИЧЕСКИЕ

infection in AIDS. // J Infect. – 2002. – Vol. 44. – Р.166–70.

 

183. Von Rhein C.F., Waddell R.D., Eaton T. et al. Isolation of Mycobacterium

 

avium complex from water in the United States, Finland, Zaire, and Kenya.

 

// J Clin Microbiol. 1993. – Vol. 12. – P. 3227–3230.

 

184. Walker N.J. A Technique whose time has come // J. Science. – 2002. –

4.

Vol. 296. – P. 557–559.

Раздел

 

 

 

 

 

527